We are live on ! Find out more
T

TOBAM Portfolio holdings

AUM $412M
1-Year Est. Return 18.33%
This Fund
S&P 500
This Quarter Est. Return
+0.57%
1 Year Est. Return
+18.33%
3 Year Est. Return
+56.05%
5 Year Est. Return
+49%
10 Year Est. Return
+255.15%
AUM
$234M
AUM Growth
-$93.7M
Cap. Flow
-$86.8M
Cap. Flow %
-37.11%
Top 10 Hldgs %
27.68%
Holding
338
New
19
Increased
53
Reduced
178
Closed
87

Top Buys

Rank Stock Value
1
EA
Electronic Arts
EA
+$3.29M
2
WST icon
West Pharmaceutical
WST
+$2.66M
3
AVGO icon
Broadcom
AVGO
+$2.25M
4
AXON
Axon Enterprise
AXON
+$2.12M
5
NKE icon
Nike
NKE
+$2.06M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.16M
2
UTHR icon
United Therapeutics
UTHR
+$4.06M
3
RBA icon
RB Global
RBA
+$3.88M
4
TTC icon
Toro Company
TTC
+$3.77M
5
SJM icon
J.M. Smucker
SJM
+$3.5M

Sector Composition

Rank Sector Weight
1 Healthcare 25.08%
2 Consumer Staples 21.87%
3 Technology 13.57%
4 Financials 11.99%
5 Communication Services 10.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
T icon
1
AT&T
T
$176B
$7.11M 3.04%
251,234
-131,067
-34% -$3.3M
CBOE icon
2
Cboe Global Markets
CBOE
$31.2B
$7.09M 3.03%
31,339
-6,349
-17% -$1.32M
VZ icon
3
Verizon
VZ
$208B
$6.99M 2.99%
154,071
-25,519
-14% -$1.06M
GIS icon
4
General Mills
GIS
$20.5B
$6.76M 2.89%
113,137
-11,511
-9% -$691K
HSY icon
5
Hershey
HSY
$34.8B
$6.65M 2.84%
38,890
+10,301
+36% +$1.69M
MCK icon
6
McKesson
MCK
$106B
$6.52M 2.79%
9,686
-3,385
-26% -$2.09M
CHD icon
7
Church & Dwight Co
CHD
$23.4B
$6.37M 2.72%
57,850
-8,823
-13% -$944K
CLX icon
8
Clorox
CLX
$11.3B
$6.15M 2.63%
41,736
-4,022
-9% -$614K
ABBV icon
9
AbbVie
ABBV
$453B
$5.79M 2.48%
27,644
-11,629
-30% -$2.26M
LPLA icon
10
LPL Financial
LPLA
$28.3B
$5.34M 2.28%
16,331
-3,802
-19% -$1.32M
MRK icon
11
Merck
MRK
$371B
$5.17M 2.21%
57,588
-7,566
-12% -$706K
WRB icon
12
W.R. Berkley
WRB
$25.7B
$5.1M 2.18%
71,641
+1,736
+2% +$106K
DG icon
13
Dollar General
DG
$29.4B
$4.68M 2%
53,240
+4,894
+10% +$371K
CPB icon
14
Campbell Soup
CPB
$6.38B
$4.24M 1.81%
106,218
-1,411
-1% -$55.3K
LLY icon
15
Eli Lilly
LLY
$1.02T
$4.17M 1.78%
5,051
-3,421
-40% -$2.85M
CMG icon
16
Chipotle Mexican Grill
CMG
$46.8B
$4M 1.71%
79,628
-5,486
-6% -$298K
BMY icon
17
Bristol-Myers Squibb
BMY
$136B
$3.96M 1.69%
64,862
-51,420
-44% -$3M
MSTR icon
18
Strategy Inc
MSTR
$56.7B
$3.9M 1.67%
13,544
-1,384
-9% -$439K
NVDA icon
19
NVIDIA
NVDA
$5.56T
$3.66M 1.57%
33,794
-3,999
-11% -$507K
EA
20
DELISTED
Electronic Arts
EA
$3.58M 1.53%
24,773
+24,378
+6,172% +$3.29M
KDP icon
21
Keurig Dr Pepper
KDP
$44.3B
$3.33M 1.42%
97,434
+19,957
+26% +$648K
EW icon
22
Edwards Lifesciences
EW
$51.8B
$3.17M 1.35%
43,737
-15,557
-26% -$1.11M
WST icon
23
West Pharmaceutical
WST
$23.9B
$3.17M 1.35%
14,155
+9,642
+214% +$2.66M
DXCM icon
24
DexCom
DXCM
$33.2B
$3.16M 1.35%
46,241
-10,493
-18% -$856K
AKAM icon
25
Akamai
AKAM
$15.1B
$2.98M 1.27%
36,987
+735
+2% +$65.9K

Similar funds

TOBAM's Q1 2025 Portfolio in Review

As of Q1 2025, TOBAM held 338 positions worth $234M, down 29% from $328M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

TOBAM withdrew a net $86.8M in Q1 2025, closing 87 positions and reducing 178 holdings. Its most notable exit was Toro Company, an estimated $3.77M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 29% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, TOBAM opened a new position in Expeditors International worth $1.14M.

  • TOBAM's largest Q1 2025 buy was Expeditors International: 9,454 shares worth $1.14M.
  • TOBAM added most to Electronic Arts in Q1 2025, an estimated $3.29M increase.
  • TOBAM's biggest Q1 2025 reduction was Pfizer, cutting an estimated $4.16M.
  • TOBAM fully exited Toro Company in Q1 2025, selling an estimated $3.77M.
  • TOBAM's ten largest holdings make up 28% of its $234M portfolio in Q1 2025.
  • TOBAM opened 19 new positions and closed 87 in Q1 2025.
  • TOBAM's portfolio value fell 29% quarter-over-quarter to $234M.

Based on TOBAM's 13F filing for Q1 2025, filed 16 Apr 2025.